Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 6/20 | 0.36 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20626724 | 0.77 | ADORA2A (0.31) | KDM4EALDH1A1 | |
| SCHEMBL19902454 | 0.76 | KDM4E (0.37) | PDE4APDE4BKDM4EALDH1A1 | |
| SCHEMBL19902559 | 0.74 | — | — | |
| SCHEMBL17484749 | 0.64 | LMNA (0.38) | PDE4APDE4BKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL19902423 | 0.57 | KDM4E (0.35) | PDE4AKDM4EALDH1A1SMN1; SMN2PDE10A | |
| SCHEMBL17482201 | 0.56 | PDE10A (0.33) | KDM4EALDH1A1SMN1; SMN2PDE10A | |
| SCHEMBL20574990 | 0.56 | KDM4E (0.58) | PDE4APDE4BKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL17484748 | 0.56 | FBP1 (0.37) | KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL17482196 | 0.54 | MET (0.47) | KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL21623963 | 0.54 | KDM4E (0.45) | KDM4EALDH1A1SMN1; SMN2CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10174064-B2 | Photoactive energetic materials | TRIAD NATIONAL SECURITY, LLC (US) | 2019-01-08 | — | — | US | disclosed |
| US-9902748-B2 | Photoactive energetic materials | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2018-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10174064-B2 | Photoactive energetic materials | NOX5, TRPM5, MT-ND5 | PDE4A 1157/4885PDE4B 1498/4885KDM4E 3658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.